ROVI.MC

🇪🇸 ES

Laboratorios Farmaceuticos Rovi, S.A.

Healthcare

28

Price

57.40 EUR

Market cap

$2.94B

Current yield

1.7%

Avg yield

1.7%

P/E

15.9

Net debt / EBITDA

-0.12

5Y EPS growth

-11.1%

1Y return

-4.2%

Score breakdown

Current yield

Current dividend yield must be at least 8% to match the Börsdata screen.

1.7%

≥ 8%

Avg yield

Long-term average yield (5-year proxy) must also be at least 8%.

1.7%

≥ 8%

Net debt / EBITDA

Net debt below 2x EBITDA keeps leverage from eating the dividend.

-0.12

< 2

Return metric

ROE ≥ 15% signals the business earns well on equity. Falls back to ROI, ROIC or ROA when ROE is unavailable.

28.6% (ROE)

≥ 15%

P/E ratio

P/E below 15 aims to avoid overpaying for the income stream.

15.9

< 15

5Y EPS growth

5-year EPS growth ≥ 10% suggests the dividend has some underlying growth support.

-11.1%

≥ 10%

1Y performance

1-year performance ≥ 0% filters out stocks in severe near-term downtrends.

-4.2%

≥ 0%

Total score28
Dividend history

Current yield (last 12 months paid): 1.7%. Bars show each calendar year; the latest bar is year-to-date.

20171.1%(0.183 EUR)
20180.7%(0.121 EUR)
20190.3%(0.080 EUR)
20200.4%(0.175 EUR)
20210.6%(0.381 EUR)
20222.5%(0.956 EUR)
20232.0%(1.294 EUR)
20241.7%(1.104 EUR)
20251.3%(0.935 EUR)
2026 YTD1.7%(0.959 EUR)

Return metric shown: 28.6% (ROE). Yahoo does not always provide ROE; ROI, ROIC or ROA is used as a fallback.